Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Alligo - Winter timing means growth must wait until Q1

22 januari 2026

<a id="bm-comp-8b795a35-e23f-4318-8c23-d435b746440b" name="bm-comp-8b795a35-e23f-4318-8c23-d435b746440b" class="BMCustomAnchor"></a><table><tr><td bm-component-id="8b795a35-e23f-4318-8c23-d435b746440b" style="vertical-align: top; width:100.000000%;"><ul><li>Mild winter in Q4, but sequentially easing comps: organic growth -1%</li><li>Cost savings took effect in Q3, expect y-o-y margin up 0.6pp to 8.9%</li><li>Winter cold hit around 1 January, supports return to growth in Q1</li></ul></td></tr></table><a id="bm-comp-97d8e338-b441-4621-a0f3-42ce106c4c03" name="bm-comp-97d8e338-b441-4621-a0f3-42ce106c4c03" class="BMCustomAnchor"></a><table><tr><td bm-component-id="97d8e338-b441-4621-a0f3-42ce106c4c03" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q4 expectations</h3><p>The winter in Q4 was very mild, which is negative for Alligo due to demand for important product categories such as hydraulics and winter clothing correlating inversely with temperature. However, the winter in the comparison period was also very mild, and given unchanged underlying demand q-o-q and a sequential easing of comparative figures, this leads us to forecast organic growth of -1% vs. -3% in Q3. On the adj. EBITA margin, we expect a y-o-y improvement to 8.9% (8.3%) due to the cost savings that took effect in Q3.</p><h3 class="bm-h3">Estimate changes</h3><p>We only fine-tune our '26-'27 estimates, trimming adj. EBITA by 2%, half of which is due to FX.</p><h3 class="bm-h3">Outlook &amp; valuation</h3><p>Investors are still awaiting the announcement of a successor to outgoing CEO Clein Ullenvik, but in the meantime, cold winter weather hit the Nordics properly around 1 January, boding well for our forecast of a return to organic growth in Q1 (3%) for the first time in 11 quarters. This should support our full-year estimate of 4.5% organic growth, which in turn enables margin expansion from 6.4% to 7.4%, as the drop-through on new volumes should be high. The share is currently trading at a '26e-'27e P/E of 14-11x, and we reiterate our fair value range of SEK 110-200.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-02-06 Nolato - An unexpected hiccup in the earnings trend Nolato Analys
2026-02-06 Studsvik - FM&WT momentum builds Studsvik Analys
2026-02-06 CTT Systems - Soft Q4, partly expected, growth in... CTT Systems Analys
2026-02-05 Ascelia Pharma - Preparing for a US approval and ... Ascelia Pharma Analys
2026-02-05 I-tech - A pause in pace, not the story I-tech Analys
2026-02-05 Eastnine - Estimates likely coming down 1-2% Eastnine Analys
2026-02-05 Studsvik - FM&WM shines, Decommissioning lags Studsvik Analys
2026-02-05 I-tech - Customer pullback weighing on growth I-tech Analys
2026-02-04 Svedbergs Group - Project market showing recovery Svedbergs G.. Analys
2026-02-04 Svedbergs Group - Q4: Sweden shows strength Svedbergs G.. Analys
2026-02-03 B3 Consulting Group - Higher chance of positive n... B3 Consulti.. Analys
2026-02-03 Generic - Margins over volumes Generic Analys
2026-02-03 OssDsign - Scaling towards profitability OssDsign Analys
2026-02-03 OssDsign - Lower sales but higher gross margin OssDsign Analys
2026-02-02 Ovzon - Orders stacking up for another strong year Ovzon Analys
2026-02-02 Byggmästaren - Private assets performing, valuati... Byggmästaren Analys
2026-02-02 Midsona - Brighter days ahead Midsona Analys
2026-01-30 Prevas - A cautious close to 2025 Prevas Analys
2026-01-30 Midsona - Closing the year in style Midsona Analys
2026-01-29 I-tech - No easy lap into Q4e I-tech Analys